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Introduction
Involvement of the reticuloendothelial system occurs in
20-50% childhood-onset systemic lupus erythematosus
(c-SLE) patients at disease onset, usually associated with
disease activity. Hepatomegaly and/or splenomegaly may
also be associated with abnormal liver function tests.
Abdominal ultrasound can be used to assess liver and
spleen measurements in children and adolescents with-
out risk of radiation. However, a systematic evaluation of
these visceral organ dimensions has not been performed
in c-SLE population, particularly during the disease
course.
Objectives
To evaluate liver and spleen dimensions in c-SLE patients
and healthy controls and to assess possible associations
between abnormalities in liver and spleen sizes with demo-
graphic data, clinical features, disease activity, cumulative
damage and treatment.
Methods
30 c-SLE patients and 30 healthy control volunteers
underwent abdominal ultrasound. The following two liver
measurements were performed in left hepatic lobe: cranio-
caudal and anteroposterior and three in right hepatic lobe
(RHL): posterior craniocaudal (PCC-RHL), anterior cra-
niocaudal and anteroposterior. Three spleen dimension
measurements were also evaluated: longitudinal, transverse
and anteroposterior. Demographic, clinical and laborator-
ial data, and treatment were assessed. Disease activity was
evaluated according to SLE Disease Activity Index 2000
(SLEDAI-2K), European Consensus Lupus Activity
Measurement (ECLAM) and Systemic Lupus Activity
Measure (SLAM) scores.
Results
Mean current age was similar in c-SLE and controls
(170.31 ± 27.81 vs. 164.15 ± 39.25 months; p=0.486),
likewise the frequency of female gender (77% vs. 63%,
p=0.398). The mean of PCC-RHL dimension was signifi-
cantly higher in c-SLE compared to controls (13.30 ±
1.85 vs. 12.52 ± 0.93, p=0.044). There were no differ-
ences between the other hepatic biometrics and splenic
parameters (p>0.05). Further analysis in c-SLE patients
according to PCC-RHL dimension > 13.3 cm (mean of
this biometric measurement in 30 c-SLE patients) versus <
13.3 cm showed that the median of SLEDAI-2K [8 (0-18)
vs. 2 (0-8), p=0.004], ECLAM [4 (0-9) vs. 2 (0-5), p=0.019]
and SLAM [5 (1-13) vs. 2 (0-14), p=0.016] were signifi-
cantly higher in patients with higher PCC-RHL dimension,
likewise the mean of erythrocyte sedimentation rate (33.7
± 16 vs. 22.0 ± 13 mm/1st hour, p=0.038). The frequencies
of nephritis were significantly higher in patients with
PCC-RHL dimension > 13.3 cm versus < 13.3 cm (77% vs.
29%, p=0.010). The median of serum liver enzymes were
similar in both groups (p>0.05). Positive correlation was
observed between SLEDAI-2K and PCC-RHL (p=0.001,
r=+0.595). Negative correlation was evidenced between
disease duration and longitudinal dimension of spleen
(p=0.031, r=-0.394).
Conclusion
Our data raises the novel possibility that disease activity
could lead to a subclinical and localized hepatomegaly
during the disease course. Long disease duration
resulted to spleen atrophy in c-SLE patients.
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